Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Dow
Cipla
US Department of Justice
Johnson and Johnson
Medtronic
UBS
Citi
Chubb
Argus Health

Generated: October 20, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,756,541

« Back to Dashboard

Summary for Patent: 5,756,541

Title: Vision through photodynamic therapy of the eye
Abstract:Photodynamic therapy of conditions of the eye, especially those conditions characterized by unwanted neovasculature, such as age-related macular degeneration, results in enhanced visual acuity for treated subjects,
Inventor(s): Strong; H. Andrew (North Van., CA), Levy; Julia (Vancouver, CA), Huber; Gustav (Zurich, CH), Fsadni; Mario (Buelach, CH)
Assignee: QLT Phototherapeutics Inc (Vancouver, CA)
Application Number:08/613,420
Patent Claim Types:
see list of patent claims
Formulation; Compound; Use;

No matches for this query

International Patent Family for Patent: 5,756,541

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Japan2000506173► Subscribe
Israel220210► Subscribe
Israel220143► Subscribe
Israel187758► Subscribe
Israel126099► Subscribe
Hungary227978► Subscribe
Hungary9902012► Subscribe
Japan2006273853► Subscribe
Poland328796► Subscribe
Norway984163► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Federal Trade Commission
Moodys
McKesson
QuintilesIMS
Fish and Richardson
McKinsey
Novartis
Boehringer Ingelheim
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot